JMJ Fintech Limited has officially confirmed that there has been no deviation or variation in the utilization of funds raised through its recent Rights Issue. This confirmation pertains to the use of proceeds for the quarter ended September 30, 2026, as per the objects stated in the ‘Letter of Offer’ dated July 12, 2025. The company submitted this statement, reviewed by the Audit Committee, to the BSE.
JMJ Fintech Clarifies Fund Utilization
JMJ Fintech Limited has issued a statement to the BSE confirming that it has adhered strictly to the stated objectives for the utilization of funds raised through its recent Rights Issue. This disclosure is made in compliance with Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Adherence to Stated Objects
The company specified that the funds raised from the Rights Issue, which involved the issuance of 2,48,45,548 fully paid-up equity shares and 7,54,452 partly paid equity shares, have been used without any deviation. The original objects for raising these funds were detailed in the ‘Letter of Offer’ dated July 12, 2025. Specifically, the statement covers the quarter ended September 30, 2026.
Financial Overview for the Quarter
For the quarter ended September 30, 2026, JMJ Fintech reported that proceeds amounting to ₹26,32,54,777.80 from fully paid-up equity shares were utilized as per the disclosed plans. This information is detailed further in the attached ‘Annexure A’.
Audit Committee Review
A statement confirming the absence of deviation or variation in the utilization of these proceeds for the quarter ended September 30, 2026, has been duly reviewed by the Audit Committee through circulation. This review was completed and the statement was finalized on November 03, 2026.
Detailed Breakdown of Fund Utilization
The attached statement provides a granular view of how the funds were allocated. The original objects included augmenting capital, providing for fund requirements for increasing operational scale with respect to NBFC activities, general corporate purposes, and issue-related expenses. For instance, ₹1900.00 Lakhs were originally allocated to augment capital, with ₹1899.66 Lakhs utilized. General corporate purposes saw an allocation of ₹672.00 Lakhs with ₹464.15 Lakhs utilized, and issue-related expenses had an allocation of ₹116.00 Lakhs with ₹108.65 Lakhs utilized. In all these categories, there has been no deviation reported.
Source: BSE
